Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer.
Ichikawa H, Usui K, Aizawa M, Shimada Y, Muneoka Y, Kano Y, Sugai M, Moro K, Hirose Y, Miura K, Sakata J, Yabusaki H, Nakagawa S, Kawasaki T, Umezu H, Okuda S, Wakai T.
Ichikawa H, et al. Among authors: shimada y.
BMC Cancer. 2024 Jun 11;24(1):719. doi: 10.1186/s12885-024-12482-5.
BMC Cancer. 2024.
PMID: 38862927
Free PMC article.